Breaking News: CNMD latest news.

Sunday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Conference/Events	Society for Robotic Surgery to hold a virtual symposium » 04:55 08/02/20 08/02 04:55 08/02/20 04:55 BDX Becton Dickinson $281.26 / +7.205 (+2.63%) , CNMD Conmed $82.46 / -4.87 (-5.58%) , EXAS Exact Sciences $94.76 / -3.1 (-3.17%) , TFX Teleflex $372.64 / -11.37 (-2.96%) , PCRX Pacira $52.62 / -0.45 (-0.85%) World Robotic Virtual… World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TFX PCRX EXAS CNMD BDX TFX Teleflex $372.64 / -11.37 (-2.96%) 07/30/20 Teleflex discloses False Claims Act investigation by Justice Department 07/30/20 Teleflex announces new workforce reduction plan 07/21/20 Teleflex announces data from three studies of UroLift System 06/22/20 Teleflex: Data published shows UroLift System as superior treatment to Rezum PCRX Pacira $52.62 / -0.45 (-0.85%) 07/28/20 Pacira announces government investigation settlement for Exparel, to pay $3.5M 07/02/20 Pacira concludes EXPAREL agreement with DePuy Synthes 06/29/20 Heron receives Complete Response Letter from FDA for pain treatment 06/29/20 Pacira jumps 6% after Heron pain drug given Complete Response Letter EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/23/20 Humana mailing over 1M in-home preventive care screening kits to members in 2020 06/16/20 Exact Sciences announces publication on Oncotype DX Genomic Prostate Score 05/14/20 Exact Sciences announces results from Oncotype DX clinical survey at ASCO 04/17/20 Exact Sciences receives FDA EUAoapproval for COVID-19 test CNMD Conmed $82.46 / -4.87 (-5.58%) 07/29/20 Conmed not providing FY20 guidance 04/20/20 Conmed announces amendment to existing credit agreement 03/31/20 Conmed says annual meeting of shareholders to be held virtually 03/16/20 Conmed CEO Curt Hartman to succeed Mark Tryniski as chair of the board BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 07/30/20 Becton Dickinson receives $24M investment to scale up COVID-19 tests 07/22/20 Becton Dickinson receives FDA approval for BD Onclarity HPV Assay PMA supplement 07/15/20 Becton Dickinson announces commitment from HHS to purchase COVID-19 solutions 07/06/20 FDA alerts clinical lab staff on COVID false positives risk with BD Max System BDX CNMD EXAS TFX PCRX BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 07/09/20 Fly Intel: Top five analyst upgrades 07/09/20 Barclays Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity' 07/09/20 Barclays Becton Dickinson upgraded to Overweight from Equal Weight at Barclays 07/02/20 Wells Fargo Becton rallies after Wells says rapid COVID test may come very soon CNMD Conmed $82.46 / -4.87 (-5.58%) 07/29/20 Piper Sandler Conmed price target raised to $95 from $90 at Piper Sandler 04/30/20 Piper Sandler Conmed price target lowered to $90 from $110 at Piper Sandler 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/31/20 Benchmark Exact Sciences price target raised to $110 from $90 at Benchmark 07/31/20 Citi Exact Sciences price target raised to $120 from $110 at Citi 07/23/20 Evercore ISI Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard 07/23/20 Evercore ISI Humana plans could boost Exact's growth as much as 12%, says Evercore ISI TFX Teleflex $372.64 / -11.37 (-2.96%) 07/30/20 Piper Sandler Teleflex selloff on DOJ investigation should be bought, says Piper Sandler 06/09/20 Wells Fargo Teleflex price target raised to $425 from $375 at Wells Fargo 06/04/20 SVB Leerink Teleflex price target raised to $425 from $400 at SVB Leerink 05/01/20 Piper Sandler Teleflex price target lowered to $375 from $425 at Piper Sandler PCRX Pacira $52.62 / -0.45 (-0.85%) 07/13/20 H.C. Wainwright Pacira price target raised to $68 from $63 at H.C. Wainwright 07/10/20 Jefferies Pacira price target raised to $69 from $53 at Jefferies 07/06/20 Needham Pacira price target raised to $64 from $52 at Needham 07/06/20 Piper Sandler Pacira price target raised to $65 from $49 at Piper Sandler TFX PCRX EXAS CNMD BDX TFX Teleflex $372.64 / -11.37 (-2.96%) 07/30/20 Teleflex not reinstating FY20 guidance due to COVID-19 pandemic 07/30/20 Teleflex reports Q2 adjusted EPS $1.93, consensus $1.25 04/30/20 Teleflex withdraws 2020 guidance 04/30/20 Teleflex reports Q1 adjusted EPS $2.72, consensus $2.35 PCRX Pacira $52.62 / -0.45 (-0.85%) 07/06/20 Pacira reports preliminary Q2 revenue $75.5M, consensus $57.81M 05/07/20 Pacira withdraws FY20 guidance 05/07/20 Pacira reports Q1 adj. EPS 54c, consensus 31c 02/20/20 Pacira sees FY20 revenue $485M-$500M, consensus $495.91M EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/30/20 Exact Sciences reports Q2 EPS (58c), consensus (63c) 07/30/20 Notable companies reporting after market close 05/06/20 Exact Sciences reports Q1 EPS (71c), consensus (61c) 04/21/20 Exact Sciences reports preliminary Q1 revenue about $348M, consensus $343.04M CNMD Conmed $82.46 / -4.87 (-5.58%) 07/29/20 Conmed reports Q2 EPS (7c), consensus (95c) 04/29/20 Conmed withdraws 2020 guidance 04/29/20 Conmed reports Q1 adjusted EPS 51c, consensus 46c 03/20/20 Conmed pulls guidance, sees possible 'material disruption' from COVID-19 BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 05/07/20 Becton Dickinson withdraws FY20 guidance amid COVID-19 pandemic 05/07/20 Becton Dickinson reports Q2 adj. EPS $2.55, consensus $2.36 05/06/20 Notable companies reporting before tomorrow's open 21 May PCRX EXAS BDX PCRX Pacira $52.62 / -0.45 (-0.85%) 07/06/20 Fly Intel: After-Hours Movers 06/29/20 Pacira jumps as competitor Heron receives CRL for pain treatment EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/23/20 Exact Sciences higher after Humana announces in-home test plans BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 07/06/20 Fly Intel: Wall Street's top stories for Monday 07/06/20 Fly Intel: Wall Street's top stories at midday 07/06/20 Fly Intel: Pre-market Movers 05/19/20 Fly Intel: After-Hours Movers 08/11/20 Wedbush Pacgrow Healthcare Virtual Conference 08/05/20 Teleflex - TFX 08/06/20 Becton Dickinson - BDX 08/06/20 Pacira - PCRX EXAS EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 04/02/20 EXACT Sciences call volume above normal and directionally bullish 02/11/20 EXACT Sciences options imply 10.9% move in share price post-earnings

Saturday
Conference/Events	Society for Robotic Surgery to hold a virtual symposium » 04:55 08/01/20 08/01 04:55 08/01/20 04:55 BDX Becton Dickinson $281.26 / +7.205 (+2.63%) , CNMD Conmed $82.46 / -4.87 (-5.58%) , EXAS Exact Sciences $94.76 / -3.1 (-3.17%) , TFX Teleflex $372.64 / -11.37 (-2.96%) , PCRX Pacira $52.62 / -0.45 (-0.85%) World Robotic Virtual… World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TFX PCRX EXAS CNMD BDX TFX Teleflex $372.64 / -11.37 (-2.96%) 07/30/20 Teleflex discloses False Claims Act investigation by Justice Department 07/30/20 Teleflex announces new workforce reduction plan 07/21/20 Teleflex announces data from three studies of UroLift System 06/22/20 Teleflex: Data published shows UroLift System as superior treatment to Rezum PCRX Pacira $52.62 / -0.45 (-0.85%) 07/28/20 Pacira announces government investigation settlement for Exparel, to pay $3.5M 07/02/20 Pacira concludes EXPAREL agreement with DePuy Synthes 06/29/20 Heron receives Complete Response Letter from FDA for pain treatment 06/29/20 Pacira jumps 6% after Heron pain drug given Complete Response Letter EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/23/20 Humana mailing over 1M in-home preventive care screening kits to members in 2020 06/16/20 Exact Sciences announces publication on Oncotype DX Genomic Prostate Score 05/14/20 Exact Sciences announces results from Oncotype DX clinical survey at ASCO 04/17/20 Exact Sciences receives FDA EUAoapproval for COVID-19 test CNMD Conmed $82.46 / -4.87 (-5.58%) 07/29/20 Conmed not providing FY20 guidance 04/20/20 Conmed announces amendment to existing credit agreement 03/31/20 Conmed says annual meeting of shareholders to be held virtually 03/16/20 Conmed CEO Curt Hartman to succeed Mark Tryniski as chair of the board BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 07/30/20 Becton Dickinson receives $24M investment to scale up COVID-19 tests 07/22/20 Becton Dickinson receives FDA approval for BD Onclarity HPV Assay PMA supplement 07/15/20 Becton Dickinson announces commitment from HHS to purchase COVID-19 solutions 07/06/20 FDA alerts clinical lab staff on COVID false positives risk with BD Max System BDX CNMD EXAS TFX PCRX BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 07/09/20 Fly Intel: Top five analyst upgrades 07/09/20 Barclays Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity' 07/09/20 Barclays Becton Dickinson upgraded to Overweight from Equal Weight at Barclays 07/02/20 Wells Fargo Becton rallies after Wells says rapid COVID test may come very soon CNMD Conmed $82.46 / -4.87 (-5.58%) 07/29/20 Piper Sandler Conmed price target raised to $95 from $90 at Piper Sandler 04/30/20 Piper Sandler Conmed price target lowered to $90 from $110 at Piper Sandler 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/31/20 Benchmark Exact Sciences price target raised to $110 from $90 at Benchmark 07/31/20 Citi Exact Sciences price target raised to $120 from $110 at Citi 07/23/20 Evercore ISI Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard 07/23/20 Evercore ISI Humana plans could boost Exact's growth as much as 12%, says Evercore ISI TFX Teleflex $372.64 / -11.37 (-2.96%) 07/30/20 Piper Sandler Teleflex selloff on DOJ investigation should be bought, says Piper Sandler 06/09/20 Wells Fargo Teleflex price target raised to $425 from $375 at Wells Fargo 06/04/20 SVB Leerink Teleflex price target raised to $425 from $400 at SVB Leerink 05/01/20 Piper Sandler Teleflex price target lowered to $375 from $425 at Piper Sandler PCRX Pacira $52.62 / -0.45 (-0.85%) 07/13/20 H.C. Wainwright Pacira price target raised to $68 from $63 at H.C. Wainwright 07/10/20 Jefferies Pacira price target raised to $69 from $53 at Jefferies 07/06/20 Needham Pacira price target raised to $64 from $52 at Needham 07/06/20 Piper Sandler Pacira price target raised to $65 from $49 at Piper Sandler TFX PCRX EXAS CNMD BDX TFX Teleflex $372.64 / -11.37 (-2.96%) 07/30/20 Teleflex not reinstating FY20 guidance due to COVID-19 pandemic 07/30/20 Teleflex reports Q2 adjusted EPS $1.93, consensus $1.25 04/30/20 Teleflex withdraws 2020 guidance 04/30/20 Teleflex reports Q1 adjusted EPS $2.72, consensus $2.35 PCRX Pacira $52.62 / -0.45 (-0.85%) 07/06/20 Pacira reports preliminary Q2 revenue $75.5M, consensus $57.81M 05/07/20 Pacira withdraws FY20 guidance 05/07/20 Pacira reports Q1 adj. EPS 54c, consensus 31c 02/20/20 Pacira sees FY20 revenue $485M-$500M, consensus $495.91M EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/30/20 Exact Sciences reports Q2 EPS (58c), consensus (63c) 07/30/20 Notable companies reporting after market close 05/06/20 Exact Sciences reports Q1 EPS (71c), consensus (61c) 04/21/20 Exact Sciences reports preliminary Q1 revenue about $348M, consensus $343.04M CNMD Conmed $82.46 / -4.87 (-5.58%) 07/29/20 Conmed reports Q2 EPS (7c), consensus (95c) 04/29/20 Conmed withdraws 2020 guidance 04/29/20 Conmed reports Q1 adjusted EPS 51c, consensus 46c 03/20/20 Conmed pulls guidance, sees possible 'material disruption' from COVID-19 BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 05/07/20 Becton Dickinson withdraws FY20 guidance amid COVID-19 pandemic 05/07/20 Becton Dickinson reports Q2 adj. EPS $2.55, consensus $2.36 05/06/20 Notable companies reporting before tomorrow's open 21 May PCRX EXAS BDX PCRX Pacira $52.62 / -0.45 (-0.85%) 07/06/20 Fly Intel: After-Hours Movers 06/29/20 Pacira jumps as competitor Heron receives CRL for pain treatment EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 07/23/20 Exact Sciences higher after Humana announces in-home test plans BDX Becton Dickinson $281.26 / +7.205 (+2.63%) 07/06/20 Fly Intel: Wall Street's top stories for Monday 07/06/20 Fly Intel: Wall Street's top stories at midday 07/06/20 Fly Intel: Pre-market Movers 05/19/20 Fly Intel: After-Hours Movers 08/11/20 Wedbush Pacgrow Healthcare Virtual Conference 08/05/20 Teleflex - TFX 08/06/20 Becton Dickinson - BDX 08/06/20 Pacira - PCRX EXAS EXAS Exact Sciences $94.76 / -3.1 (-3.17%) 04/02/20 EXACT Sciences call volume above normal and directionally bullish 02/11/20 EXACT Sciences options imply 10.9% move in share price post-earnings

Friday
Conference/Events	Society for Robotic Surgery to hold a virtual symposium » 04:55 07/31/20 07/31 04:55 07/31/20 04:55 BDX Becton Dickinson $274.05 / -2.22 (-0.80%) , CNMD Conmed $87.33 / +0.86 (+0.99%) , EXAS Exact Sciences $97.86 / +3.38 (+3.58%) , TFX Teleflex $384.01 / -19.34 (-4.79%) , PCRX Pacira $53.07 / +0.53 (+1.01%) World Robotic Virtual… World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TFX PCRX EXAS CNMD BDX TFX Teleflex $384.01 / -19.34 (-4.79%) 07/30/20 Teleflex discloses False Claims Act investigation by Justice Department 07/30/20 Teleflex announces new workforce reduction plan 07/21/20 Teleflex announces data from three studies of UroLift System 06/22/20 Teleflex: Data published shows UroLift System as superior treatment to Rezum PCRX Pacira $53.07 / +0.53 (+1.01%) 07/28/20 Pacira announces government investigation settlement for Exparel, to pay $3.5M 07/02/20 Pacira concludes EXPAREL agreement with DePuy Synthes 06/29/20 Heron receives Complete Response Letter from FDA for pain treatment 06/29/20 Pacira jumps 6% after Heron pain drug given Complete Response Letter EXAS Exact Sciences $97.86 / +3.38 (+3.58%) 07/23/20 Humana mailing over 1M in-home preventive care screening kits to members in 2020 06/16/20 Exact Sciences announces publication on Oncotype DX Genomic Prostate Score 05/14/20 Exact Sciences announces results from Oncotype DX clinical survey at ASCO 04/17/20 Exact Sciences receives FDA EUAoapproval for COVID-19 test CNMD Conmed $87.33 / +0.86 (+0.99%) 07/29/20 Conmed not providing FY20 guidance 04/20/20 Conmed announces amendment to existing credit agreement 03/31/20 Conmed says annual meeting of shareholders to be held virtually 03/16/20 Conmed CEO Curt Hartman to succeed Mark Tryniski as chair of the board BDX Becton Dickinson $274.05 / -2.22 (-0.80%) 07/30/20 Becton Dickinson receives $24M investment to scale up COVID-19 tests 07/22/20 Becton Dickinson receives FDA approval for BD Onclarity HPV Assay PMA supplement 07/15/20 Becton Dickinson announces commitment from HHS to purchase COVID-19 solutions 07/06/20 FDA alerts clinical lab staff on COVID false positives risk with BD Max System BDX CNMD EXAS TFX PCRX BDX Becton Dickinson $274.05 / -2.22 (-0.80%) 07/09/20 Fly Intel: Top five analyst upgrades 07/09/20 Barclays Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity' 07/09/20 Barclays Becton Dickinson upgraded to Overweight from Equal Weight at Barclays 07/02/20 Wells Fargo Becton rallies after Wells says rapid COVID test may come very soon CNMD Conmed $87.33 / +0.86 (+0.99%) 07/29/20 Piper Sandler Conmed price target raised to $95 from $90 at Piper Sandler 04/30/20 Piper Sandler Conmed price target lowered to $90 from $110 at Piper Sandler 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler EXAS Exact Sciences $97.86 / +3.38 (+3.58%) 07/23/20 Evercore ISI Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard 07/23/20 Evercore ISI Humana plans could boost Exact's growth as much as 12%, says Evercore ISI 06/25/20 Citi Citi opens 'positive catalyst watch' on Exact Sciences, boosts target 05/13/20 Evercore ISI Exact Sciences comments imply volumes last week down 40% YoY, says Evercore ISI TFX Teleflex $384.01 / -19.34 (-4.79%) 07/30/20 Piper Sandler Teleflex selloff on DOJ investigation should be bought, says Piper Sandler 06/09/20 Wells Fargo Teleflex price target raised to $425 from $375 at Wells Fargo 06/04/20 SVB Leerink Teleflex price target raised to $425 from $400 at SVB Leerink 05/01/20 Piper Sandler Teleflex price target lowered to $375 from $425 at Piper Sandler PCRX Pacira $53.07 / +0.53 (+1.01%) 07/13/20 H.C. Wainwright Pacira price target raised to $68 from $63 at H.C. Wainwright 07/10/20 Jefferies Pacira price target raised to $69 from $53 at Jefferies 07/06/20 Needham Pacira price target raised to $64 from $52 at Needham 07/06/20 Piper Sandler Pacira price target raised to $65 from $49 at Piper Sandler TFX PCRX EXAS CNMD BDX TFX Teleflex $384.01 / -19.34 (-4.79%) 07/30/20 Teleflex not reinstating FY20 guidance due to COVID-19 pandemic 07/30/20 Teleflex reports Q2 adjusted EPS $1.93, consensus $1.25 04/30/20 Teleflex withdraws 2020 guidance 04/30/20 Teleflex reports Q1 adjusted EPS $2.72, consensus $2.35 PCRX Pacira $53.07 / +0.53 (+1.01%) 07/06/20 Pacira reports preliminary Q2 revenue $75.5M, consensus $57.81M 05/07/20 Pacira withdraws FY20 guidance 05/07/20 Pacira reports Q1 adj. EPS 54c, consensus 31c 02/20/20 Pacira sees FY20 revenue $485M-$500M, consensus $495.91M EXAS Exact Sciences $97.86 / +3.38 (+3.58%) 07/30/20 Exact Sciences reports Q2 EPS (58c), consensus (63c) 07/30/20 Notable companies reporting after market close 05/06/20 Exact Sciences reports Q1 EPS (71c), consensus (61c) 04/21/20 Exact Sciences reports preliminary Q1 revenue about $348M, consensus $343.04M CNMD Conmed $87.33 / +0.86 (+0.99%) 07/29/20 Conmed reports Q2 EPS (7c), consensus (95c) 04/29/20 Conmed withdraws 2020 guidance 04/29/20 Conmed reports Q1 adjusted EPS 51c, consensus 46c 03/20/20 Conmed pulls guidance, sees possible 'material disruption' from COVID-19 BDX Becton Dickinson $274.05 / -2.22 (-0.80%) 05/07/20 Becton Dickinson withdraws FY20 guidance amid COVID-19 pandemic 05/07/20 Becton Dickinson reports Q2 adj. EPS $2.55, consensus $2.36 05/06/20 Notable companies reporting before tomorrow's open 21 May PCRX EXAS BDX PCRX Pacira $53.07 / +0.53 (+1.01%) 07/06/20 Fly Intel: After-Hours Movers 06/29/20 Pacira jumps as competitor Heron receives CRL for pain treatment EXAS Exact Sciences $97.86 / +3.38 (+3.58%) 07/23/20 Exact Sciences higher after Humana announces in-home test plans BDX Becton Dickinson $274.05 / -2.22 (-0.80%) 07/06/20 Fly Intel: Wall Street's top stories for Monday 07/06/20 Fly Intel: Wall Street's top stories at midday 07/06/20 Fly Intel: Pre-market Movers 05/19/20 Fly Intel: After-Hours Movers 08/11/20 Wedbush Pacgrow Healthcare Virtual Conference 08/05/20 Teleflex - TFX 08/06/20 Becton Dickinson - BDX 08/06/20 Pacira - PCRX EXAS EXAS Exact Sciences $97.86 / +3.38 (+3.58%) 04/02/20 EXACT Sciences call volume above normal and directionally bullish 02/11/20 EXACT Sciences options imply 10.9% move in share price post-earnings

Thursday
Conference/Events	Society for Robotic Surgery to hold a virtual symposium » 09:15 07/30/20 07/30 09:15 07/30/20 09:15 BDX Becton Dickinson $276.27 / +3.18 (+1.16%) , CNMD Conmed $86.47 / +3.665 (+4.43%) , EXAS Exact Sciences $94.48 / -0.32 (-0.34%) , TFX Teleflex $403.35 / +18.1 (+4.70%) , PCRX Pacira $52.54 / +0.61 (+1.17%) World Robotic Virtual… World Robotic Virtual Symposium 2020 will be held on July 30-August 2. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TFX PCRX EXAS CNMD BDX TFX Teleflex $403.35 / +18.1 (+4.70%) 07/30/20 Teleflex announces new workforce reduction plan 07/21/20 Teleflex announces data from three studies of UroLift System 06/22/20 Teleflex: Data published shows UroLift System as superior treatment to Rezum 06/02/20 Teleflex enrolls first patient for Teleflex's clinical study PCRX Pacira $52.54 / +0.61 (+1.17%) 07/28/20 Pacira announces government investigation settlement for Exparel, to pay $3.5M 07/02/20 Pacira concludes EXPAREL agreement with DePuy Synthes 06/29/20 Heron receives Complete Response Letter from FDA for pain treatment 06/29/20 Pacira jumps 6% after Heron pain drug given Complete Response Letter EXAS Exact Sciences $94.48 / -0.32 (-0.34%) 07/23/20 Humana mailing over 1M in-home preventive care screening kits to members in 2020 06/16/20 Exact Sciences announces publication on Oncotype DX Genomic Prostate Score 05/14/20 Exact Sciences announces results from Oncotype DX clinical survey at ASCO 04/17/20 Exact Sciences receives FDA EUAoapproval for COVID-19 test CNMD Conmed $86.47 / +3.665 (+4.43%) 07/29/20 Conmed not providing FY20 guidance 04/20/20 Conmed announces amendment to existing credit agreement 03/31/20 Conmed says annual meeting of shareholders to be held virtually 03/16/20 Conmed CEO Curt Hartman to succeed Mark Tryniski as chair of the board BDX Becton Dickinson $276.27 / +3.18 (+1.16%) 07/22/20 Becton Dickinson receives FDA approval for BD Onclarity HPV Assay PMA supplement 07/15/20 Becton Dickinson announces commitment from HHS to purchase COVID-19 solutions 07/06/20 FDA alerts clinical lab staff on COVID false positives risk with BD Max System 07/06/20 Becton Dickinson launches portable, rapid point-of-care COVID-19 antigen test BDX CNMD EXAS TFX PCRX BDX Becton Dickinson $276.27 / +3.18 (+1.16%) 07/09/20 Fly Intel: Top five analyst upgrades 07/09/20 Barclays Barclays upgrades Becton Dickinson to Overweight on 'window of opportunity' 07/09/20 Barclays Becton Dickinson upgraded to Overweight from Equal Weight at Barclays 07/02/20 Wells Fargo Becton rallies after Wells says rapid COVID test may come very soon CNMD Conmed $86.47 / +3.665 (+4.43%) 07/29/20 Piper Sandler Conmed price target raised to $95 from $90 at Piper Sandler 04/30/20 Piper Sandler Conmed price target lowered to $90 from $110 at Piper Sandler 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler EXAS Exact Sciences $94.48 / -0.32 (-0.34%) 07/23/20 Evercore ISI Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard 07/23/20 Evercore ISI Humana plans could boost Exact's growth as much as 12%, says Evercore ISI 06/25/20 Citi Citi opens 'positive catalyst watch' on Exact Sciences, boosts target 05/13/20 Evercore ISI Exact Sciences comments imply volumes last week down 40% YoY, says Evercore ISI TFX Teleflex $403.35 / +18.1 (+4.70%) 06/09/20 Wells Fargo Teleflex price target raised to $425 from $375 at Wells Fargo 06/04/20 SVB Leerink Teleflex price target raised to $425 from $400 at SVB Leerink 05/01/20 Piper Sandler Teleflex price target lowered to $375 from $425 at Piper Sandler 04/03/20 Raymond James Teleflex price target lowered to $360 from $450 at Raymond James PCRX Pacira $52.54 / +0.61 (+1.17%) 07/13/20 H.C. Wainwright Pacira price target raised to $68 from $63 at H.C. Wainwright 07/10/20 Jefferies Pacira price target raised to $69 from $53 at Jefferies 07/06/20 Needham Pacira price target raised to $64 from $52 at Needham 07/06/20 Piper Sandler Pacira price target raised to $65 from $49 at Piper Sandler TFX PCRX EXAS CNMD BDX TFX Teleflex $403.35 / +18.1 (+4.70%) 07/30/20 Teleflex not reinstating FY20 guidance due to COVID-19 pandemic 07/30/20 Teleflex reports Q2 adjusted EPS $1.93, consensus $1.25 04/30/20 Teleflex withdraws 2020 guidance 04/30/20 Teleflex reports Q1 adjusted EPS $2.72, consensus $2.35 PCRX Pacira $52.54 / +0.61 (+1.17%) 07/06/20 Pacira reports preliminary Q2 revenue $75.5M, consensus $57.81M 05/07/20 Pacira withdraws FY20 guidance 05/07/20 Pacira reports Q1 adj. EPS 54c, consensus 31c 02/20/20 Pacira sees FY20 revenue $485M-$500M, consensus $495.91M EXAS Exact Sciences $94.48 / -0.32 (-0.34%) 05/06/20 Exact Sciences reports Q1 EPS (71c), consensus (61c) 04/21/20 Exact Sciences reports preliminary Q1 revenue about $348M, consensus $343.04M 02/11/20 Exact Sciences sees FY20 revenue $1.61B-$1.645B, consensus $1.59B 02/11/20 Exact Sciences reports Q4 EPS 54c, may not compare to consensus (35c) CNMD Conmed $86.47 / +3.665 (+4.43%) 07/29/20 Conmed reports Q2 EPS (7c), consensus (95c) 04/29/20 Conmed withdraws 2020 guidance 04/29/20 Conmed reports Q1 adjusted EPS 51c, consensus 46c 03/20/20 Conmed pulls guidance, sees possible 'material disruption' from COVID-19 BDX Becton Dickinson $276.27 / +3.18 (+1.16%) 05/07/20 Becton Dickinson withdraws FY20 guidance amid COVID-19 pandemic 05/07/20 Becton Dickinson reports Q2 adj. EPS $2.55, consensus $2.36 05/06/20 Notable companies reporting before tomorrow's open 21 May PCRX EXAS BDX PCRX Pacira $52.54 / +0.61 (+1.17%) 07/06/20 Fly Intel: After-Hours Movers 06/29/20 Pacira jumps as competitor Heron receives CRL for pain treatment EXAS Exact Sciences $94.48 / -0.32 (-0.34%) 07/23/20 Exact Sciences higher after Humana announces in-home test plans BDX Becton Dickinson $276.27 / +3.18 (+1.16%) 07/06/20 Fly Intel: Wall Street's top stories for Monday 07/06/20 Fly Intel: Wall Street's top stories at midday 07/06/20 Fly Intel: Pre-market Movers 05/19/20 Fly Intel: After-Hours Movers 08/01/20 World Robotic Symposium 2020 08/11/20 Wedbush Pacgrow Healthcare Virtual Conference 07/30/20 Teleflex - TFX 07/30/20 Exact Sciences - EXAS 08/05/20 Teleflex - TFX 08/06/20 Becton Dickinson - BDX 08/06/20 Pacira - PCRX EXAS EXAS Exact Sciences $94.48 / -0.32 (-0.34%) 04/02/20 EXACT Sciences call volume above normal and directionally bullish 02/11/20 EXACT Sciences options imply 10.9% move in share price post-earnings

Wednesday
Recommendations	Conmed price target raised to $95 from $90 at Piper Sandler » 21:00 07/29/20 07/29 21:00 07/29/20 21:00 CNMD Conmed $86.47 / +3.665 (+4.43%) Piper Sandler analyst… Piper Sandler analyst Matt O'Brien raised the firm's price target on Conmed to $95 from $90 and keeps an Overweight rating on the shares. The company's Q2 results topped "depressed" Q2 estimates and while the management is not offering guidance, Q3 will likely "rise meaningfully", the analyst tells investors in a research note. O'Brien adds that with COVID-19 having accelerated several cost savings initiatives, Conmed's operating margin should improve to levels above where the company has previously guided. ShowHide Related Items >><< Company News Street Research Earnings Events CNMD Conmed $86.47 / +3.665 (+4.43%) 07/29/20 Conmed not providing FY20 guidance 04/20/20 Conmed announces amendment to existing credit agreement 03/31/20 Conmed says annual meeting of shareholders to be held virtually 03/16/20 Conmed CEO Curt Hartman to succeed Mark Tryniski as chair of the board CNMD Conmed $86.47 / +3.665 (+4.43%) 04/30/20 Piper Sandler Conmed price target lowered to $90 from $110 at Piper Sandler 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler 03/10/20 Piper Sandler Conmed price target lowered to $110 from $130 at Piper Sandler CNMD Conmed $86.47 / +3.665 (+4.43%) 07/29/20 Conmed reports Q2 EPS (7c), consensus (95c) 04/29/20 Conmed withdraws 2020 guidance 04/29/20 Conmed reports Q1 adjusted EPS 51c, consensus 46c 03/20/20 Conmed pulls guidance, sees possible 'material disruption' from COVID-19 08/01/20 World Robotic Symposium 2020 07/29/20 Conmed - CNMD

Hot Stocks

Conmed not providing FY20 guidance » 16:18

07/29/20

07/29

16:18

07/29/20

16:18

CNMD

Conmed

$86.46 / +3.655 (+4.41%)

Due to the continued…

Due to the continued uncertainty created by the COVID-19 pandemic, management is unable to provide financial guidance at this time.

ShowHide Related Items >><<

Company News
Street Research
Earnings
Events

CNMD Conmed

$86.46 / +3.655 (+4.41%)

CNMD Conmed

$86.46 / +3.655 (+4.41%)

04/30/20 Piper Sandler: Conmed price target lowered to $90 from $110 at Piper Sandler

04/20/20 Piper Sandler: Conmed news positive for company, entire sector, says Piper Sandler

03/20/20 Piper Sandler: Conmed results to bounce back 'fairly quickly,' says Piper Sandler

03/10/20 Piper Sandler: Conmed price target lowered to $110 from $130 at Piper Sandler

CNMD Conmed

$86.46 / +3.655 (+4.41%)

Earnings

Conmed reports Q2 EPS (7c), consensus (95c) » 16:18

07/29/20

07/29

16:18

07/29/20

16:18

CNMD

Conmed

$86.46 / +3.655 (+4.41%)

Reports Q2 revenue…

Reports Q2 revenue $157.8M, consensus $126.59M. Curt R. Hartman, CONMED's CEO says: "The month-over-month improvements in our revenue, profitability, and cash flow over the course of the quarter are encouraging signs. While we expect continued uncertainty as a result of the COVID-19 crisis, we feel well positioned as we enter the second half of 2020 and beyond."

ShowHide Related Items >><<

Company News
Street Research
Earnings
Events

CNMD Conmed

$86.46 / +3.655 (+4.41%)

CNMD Conmed

$86.46 / +3.655 (+4.41%)

04/30/20 Piper Sandler: Conmed price target lowered to $90 from $110 at Piper Sandler

04/20/20 Piper Sandler: Conmed news positive for company, entire sector, says Piper Sandler

03/20/20 Piper Sandler: Conmed results to bounce back 'fairly quickly,' says Piper Sandler

03/10/20 Piper Sandler: Conmed price target lowered to $110 from $130 at Piper Sandler

CNMD Conmed

$86.46 / +3.655 (+4.41%)

Over a quarter ago
Recommendations	Conmed price target lowered to $90 from $110 at Piper Sandler » 05:13 04/30/20 04/30 05:13 04/30/20 05:13 CNMD Conmed $74.34 / +6.68 (+9.87%) Piper Sandler analyst… Piper Sandler analyst Matt O'Brien lowered the firm's price target on Conmed to $90 from $110 and keeps an Overweight rating on the shares. The company's Q1 results were impacted by the global spread of COVID-19 but its long-term opportunity remains, O'Brien tells investors in a research note. ShowHide Related Items >><< Street Research Events CNMD Conmed $74.34 / +6.68 (+9.87%) 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler 03/10/20 Piper Sandler Conmed price target lowered to $110 from $130 at Piper Sandler 11/26/19 Needham Conmed downgraded to Hold from Buy at Needham 05/21/20 CONMED Corporation
Earnings	Conmed withdraws 2020 guidance » 16:06 04/29/20 04/29 16:06 04/29/20 16:06 CNMD Conmed $74.58 / +6.92 (+10.23%) Healthcare providers… Healthcare providers around the globe have shifted their attention to caring for victims of the COVID-19 pandemic and preventing the spread of the virus, which has resulted in a deferral of surgical volumes. Due to the uncertainty created by this evolving dynamic, management has withdrawn its previously provided 2020 guidance, as announced on March 20, 2020, and is unable to provide reliable guidance at this time. ShowHide Related Items >><< Street Research Events CNMD Conmed $74.58 / +6.92 (+10.23%) 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler 03/10/20 Piper Sandler Conmed price target lowered to $110 from $130 at Piper Sandler 11/26/19 Needham Conmed downgraded to Hold from Buy at Needham 04/29/20 Conmed - CNMD 05/21/20 CONMED Corporation
Earnings	Conmed reports Q1 adjusted EPS 51c, consensus 46c » 16:06 04/29/20 04/29 16:06 04/29/20 16:06 CNMD Conmed $74.58 / +6.92 (+10.23%) Reports Q1 revenue $214M,… Reports Q1 revenue $214M, consensus $214.85M. "Our first quarter results were meaningfully impacted by the global COVID-19 pandemic, particularly during the second half of the quarter," commented Curt R. Hartman, CONMED's President and Chief Executive Officer. "While the current environment is challenging, we have taken decisive actions to protect our employees, solidify the financial security of the Company, and fortify the future of CONMED. Although we anticipate continued pressure in the near term, we believe our actions have positioned us to respond effectively when demand recovers." ShowHide Related Items >><< Street Research Events CNMD Conmed $74.58 / +6.92 (+10.23%) 04/20/20 Piper Sandler Conmed news positive for company, entire sector, says Piper Sandler 03/20/20 Piper Sandler Conmed results to bounce back 'fairly quickly,' says Piper Sandler 03/10/20 Piper Sandler Conmed price target lowered to $110 from $130 at Piper Sandler 11/26/19 Needham Conmed downgraded to Hold from Buy at Needham 04/29/20 Conmed - CNMD 05/21/20 CONMED Corporation

12:51	B. Riley FBR upgrades 'extremely compelling' WideOpenWest to Buy»
11:51	Evergy sinks after Bloomberg says company will remain independent»
10:25	Mallinckrodt sinks after saying bankruptcy possible in near-term»
10:14	Fly Intel: Top five analyst initiations»
10:14	Fly Intel: Top five analyst downgrades»

GWW	Grainger - GWW
MU	Micron - MU
TRSSF	TerrAscend - TRSSF
IBM	IBM Integration Technical Virtual Conference 2020
BMY	Impact of COVID-19 on Data Integrity Virtual Conference: Part I
	Virtual Hot Wheels
RCUS ...	Biotech Focus Virtual Conference 2020
	SNN Network Virtual Investor Conference 2020
	Breaking Up Big Tech: Should Congress Do It?
LIFE	aTyr Pharma

AVGR	Spot Secondary
SITE	Spot Secondary

Get Full Fly Access